What This Means for You How the Weight-Loss Pathway Opened Up From Announcement to Live Program On November 6, 2025 , the Trump administration announced agreements with Eli Lilly and Novo Nordisk to expand Medicare coverage of GLP-1 medications for obesity
Best for: Monthly tirzepatide purchases under $500 when you want short-term, interest-free installments with no formal credit application
That's the mechanism behind the "tan," and it's also exactly why the peptide's effects are so unpredictable: you're overriding a hormonal signal, not applying a topical product
1 These include imipramine (Tofranil), midodrine (ProAmatine), chlorpheniramine (Chlor-Trimeton), brompheniramine (Veltane), ephedrine (Akovaz), pseudoephedrine (Sudafed), and phenylephrine (Vazculep)